
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
High systemic immune-inflammation index predicts poor prognosis in advanced lung adenocarcinoma patients treated with EGFR-TKIs
Chao Deng, Na Zhang, Yapeng Wang, et al.
Medicine (2019) Vol. 98, Iss. 33, pp. e16875-e16875
Open Access | Times Cited: 36
Chao Deng, Na Zhang, Yapeng Wang, et al.
Medicine (2019) Vol. 98, Iss. 33, pp. e16875-e16875
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19
Shama Ahmad, Shajer Manzoor, Sazia Siddiqui, et al.
Seminars in Cancer Biology (2021) Vol. 83, pp. 384-398
Open Access | Times Cited: 76
Shama Ahmad, Shajer Manzoor, Sazia Siddiqui, et al.
Seminars in Cancer Biology (2021) Vol. 83, pp. 384-398
Open Access | Times Cited: 76
Exosomal miR-4466 from nicotine-activated neutrophils promotes tumor cell stemness and metabolism in lung cancer metastasis
Abhishek Tyagi, Shih-Ying Wu, Sambad Sharma, et al.
Oncogene (2022) Vol. 41, Iss. 22, pp. 3079-3092
Open Access | Times Cited: 65
Abhishek Tyagi, Shih-Ying Wu, Sambad Sharma, et al.
Oncogene (2022) Vol. 41, Iss. 22, pp. 3079-3092
Open Access | Times Cited: 65
Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment
Kosei Kubota, Ryohei Ito, N Narita, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 50
Kosei Kubota, Ryohei Ito, N Narita, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 50
The Relationship Between Systemic Immune Inflammatory Index and Prognosis of Patients With Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review
Wei Huang, Jiayu Luo, Jianbo Wen, et al.
Frontiers in Surgery (2022) Vol. 9
Open Access | Times Cited: 39
Wei Huang, Jiayu Luo, Jianbo Wen, et al.
Frontiers in Surgery (2022) Vol. 9
Open Access | Times Cited: 39
Predicting miscarriage using systemic immune‐inflammation index
Ezgi Turgut, Muradiye Yıldırım, Bedri Sakcak, et al.
Journal of Obstetrics and Gynaecology Research (2022) Vol. 48, Iss. 3, pp. 587-592
Closed Access | Times Cited: 26
Ezgi Turgut, Muradiye Yıldırım, Bedri Sakcak, et al.
Journal of Obstetrics and Gynaecology Research (2022) Vol. 48, Iss. 3, pp. 587-592
Closed Access | Times Cited: 26
Nomogram Based on Systemic Immune-Inflammation Index to Predict Survival of Tongue Cancer Patients Who Underwent Cervical Dissection
Zhiyuan Lu, Wangxiang Yan, Jianfeng Liang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 39
Zhiyuan Lu, Wangxiang Yan, Jianfeng Liang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 39
Impact of body composition, nutritional and inflammatory status on outcome of non-small cell lung cancer patients treated with immunotherapy
Cinzia Baldessari, Giorgia Guaitoli, Filippo Valoriani, et al.
Clinical Nutrition ESPEN (2021) Vol. 43, pp. 64-75
Closed Access | Times Cited: 32
Cinzia Baldessari, Giorgia Guaitoli, Filippo Valoriani, et al.
Clinical Nutrition ESPEN (2021) Vol. 43, pp. 64-75
Closed Access | Times Cited: 32
The prognostic value of systemic immune-inflammation index and lymphocyte-to-monocyte ratio in cases with profound sudden sensorineural hearing loss
Kun Zhao, Hui Ma
American Journal of Otolaryngology (2025), pp. 104671-104671
Open Access
Kun Zhao, Hui Ma
American Journal of Otolaryngology (2025), pp. 104671-104671
Open Access
The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors
Kaiwen Zheng, Xiangliang Liu, Wei Ji, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 5769-5785
Open Access | Times Cited: 22
Kaiwen Zheng, Xiangliang Liu, Wei Ji, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 5769-5785
Open Access | Times Cited: 22
Age-Stratified Analysis of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: Real-World Evidence from a Multicenter Retrospective Study
Takayuki Takeda, Tadaaki Yamada, Yusuke Kunimatsu, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1543-1543
Open Access | Times Cited: 9
Takayuki Takeda, Tadaaki Yamada, Yusuke Kunimatsu, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1543-1543
Open Access | Times Cited: 9
Positive association between systemic immune-inflammatory index and mortality of cardiogenic shock
Yangpei Peng, Wenwen Huang, Zhen Shi, et al.
Clinica Chimica Acta (2020) Vol. 511, pp. 97-103
Closed Access | Times Cited: 23
Yangpei Peng, Wenwen Huang, Zhen Shi, et al.
Clinica Chimica Acta (2020) Vol. 511, pp. 97-103
Closed Access | Times Cited: 23
Prognostic significance of systemic immune inflammatory index in NSCLC: a meta-analysis
Wen-Hua Chen, Jingjing Shao, Ying Yang, et al.
Lung Cancer Management (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Wen-Hua Chen, Jingjing Shao, Ying Yang, et al.
Lung Cancer Management (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors
Taihei Ono, Satoshi Igawa, Shintaro Kurahayashi, et al.
Investigational New Drugs (2020) Vol. 38, Iss. 3, pp. 885-893
Closed Access | Times Cited: 18
Taihei Ono, Satoshi Igawa, Shintaro Kurahayashi, et al.
Investigational New Drugs (2020) Vol. 38, Iss. 3, pp. 885-893
Closed Access | Times Cited: 18
The prognostic values of systemic immune-inflammation index and derived neutrophil-lymphocyte ratio in EGFR-mutant advanced non-small cell lung cancer
Şebnem YÜCEL, Burak Bi̇lgi̇n
Journal of Oncology Pharmacy Practice (2020) Vol. 27, Iss. 1, pp. 71-77
Closed Access | Times Cited: 18
Şebnem YÜCEL, Burak Bi̇lgi̇n
Journal of Oncology Pharmacy Practice (2020) Vol. 27, Iss. 1, pp. 71-77
Closed Access | Times Cited: 18
Systemic Inflammatory Markers of Survival in Epidermal Growth Factor–Mutated Non–Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis
Sze Wah Samuel Chan, Elliot Smith, Reenika Aggarwal, et al.
Clinical Lung Cancer (2021) Vol. 22, Iss. 5, pp. 390-407
Closed Access | Times Cited: 12
Sze Wah Samuel Chan, Elliot Smith, Reenika Aggarwal, et al.
Clinical Lung Cancer (2021) Vol. 22, Iss. 5, pp. 390-407
Closed Access | Times Cited: 12
Prognostic Markers of Survival among Japanese Patients with Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Receiving First-Line Alectinib
Takayuki Takeda, Tadaaki Yamada, Keiko Tanimura, et al.
Diagnostics (2021) Vol. 11, Iss. 12, pp. 2170-2170
Open Access | Times Cited: 10
Takayuki Takeda, Tadaaki Yamada, Keiko Tanimura, et al.
Diagnostics (2021) Vol. 11, Iss. 12, pp. 2170-2170
Open Access | Times Cited: 10
Predictive value of dynamic changes in peripheral blood inflammation and blood lipid-related indices for the lung cancer treatment efficacy
Yi Jiang, Chao-Ping Wang, Jiali Shen
American Journal of Cancer Research (2024) Vol. 14, Iss. 6, pp. 3130-3141
Open Access | Times Cited: 1
Yi Jiang, Chao-Ping Wang, Jiali Shen
American Journal of Cancer Research (2024) Vol. 14, Iss. 6, pp. 3130-3141
Open Access | Times Cited: 1
Hematological parameters in EGFR-mutated advanced NSCLC patients treated with TKIs: predicting survival and toxicity
Vera Jokić, Katarina Savić Vujović, Jelena Spasić, et al.
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 6, pp. 673-679
Closed Access | Times Cited: 9
Vera Jokić, Katarina Savić Vujović, Jelena Spasić, et al.
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 6, pp. 673-679
Closed Access | Times Cited: 9
Prognostic role of pretreatment lung immune prognostic index in extensive-stage small-cell lung cancer treated with platinum plus etoposide chemotherapy
Wei-Xiang Qi, Shengguang Zhao, Jiayi Chen
Cancer Biomarkers (2021) Vol. 31, Iss. 2, pp. 177-185
Closed Access | Times Cited: 8
Wei-Xiang Qi, Shengguang Zhao, Jiayi Chen
Cancer Biomarkers (2021) Vol. 31, Iss. 2, pp. 177-185
Closed Access | Times Cited: 8
Systemic Inflammation Index and Tumor Glycolytic Heterogeneity Help Risk Stratify Patients with Advanced Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitor Therapy
Kun‐Han Lue, Chun-Hou Huang, Tsung‐Cheng Hsieh, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 309-309
Open Access | Times Cited: 6
Kun‐Han Lue, Chun-Hou Huang, Tsung‐Cheng Hsieh, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 309-309
Open Access | Times Cited: 6
A high monocyte-to-lymphocyte ratio predicts poor prognosis in patients with radical cystectomy for bladder cancer
Heng Shi, Keyi Wang, Jing Yuan, et al.
Translational Cancer Research (2020) Vol. 9, Iss. 9, pp. 5255-5267
Open Access | Times Cited: 7
Heng Shi, Keyi Wang, Jing Yuan, et al.
Translational Cancer Research (2020) Vol. 9, Iss. 9, pp. 5255-5267
Open Access | Times Cited: 7
Highly elevated systemic inflammation is a strong independent predictor of early mortality in advanced non-small cell lung cancer
Johan Isaksson, Leo Wennström, Eva Brandén, et al.
Cancer Treatment and Research Communications (2022) Vol. 31, pp. 100556-100556
Open Access | Times Cited: 5
Johan Isaksson, Leo Wennström, Eva Brandén, et al.
Cancer Treatment and Research Communications (2022) Vol. 31, pp. 100556-100556
Open Access | Times Cited: 5
The relation between apical thrombus formation and systemic immune-inflammation index in patients with acute anterior myocardial infarction
Derya Tok, Firdevs Ayşenur Ekizler, Bahar Tekin Tak
Medicine (2022) Vol. 101, Iss. 50, pp. e32215-e32215
Open Access | Times Cited: 5
Derya Tok, Firdevs Ayşenur Ekizler, Bahar Tekin Tak
Medicine (2022) Vol. 101, Iss. 50, pp. e32215-e32215
Open Access | Times Cited: 5
High fibrinogen-albumin ratio index predicts poor prognosis for lung adenocarcinoma patients undergoing epidermal growth factor receptor-tyrosine kinase inhibitor treatments
Xiayan Zhao, Na Zhang, Haixia Zhang, et al.
Medicine (2020) Vol. 99, Iss. 46, pp. e23150-e23150
Open Access | Times Cited: 6
Xiayan Zhao, Na Zhang, Haixia Zhang, et al.
Medicine (2020) Vol. 99, Iss. 46, pp. e23150-e23150
Open Access | Times Cited: 6
Clinical impact of the systemic immune-inflammation index in non-small cell lung cancer patients
Fumihiro Shoji
Annals of Translational Medicine (2020) Vol. 8, Iss. 11, pp. 668-668
Open Access | Times Cited: 4
Fumihiro Shoji
Annals of Translational Medicine (2020) Vol. 8, Iss. 11, pp. 668-668
Open Access | Times Cited: 4